当前位置： SCI文献检索 > BMC Endocrine Disorders期刊下所有文献 > Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.

Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.

Abstract：

:ABSTRACT : BACKGROUND : The combination of transfusion and chelation therapy has dramatically extended the life expectancy of thalassemic patients. The main objective of this study is to determine the prevalence of prominent thalassemia complications. METHODS : Two hundred twenty patients entered the study. Physicians collected demographic and anthropometric data and the history of therapies as well as menstrual histories. Patients have been examined to determine their pubertal status. Serum levels of 25(OH) D, calcium, phosphate, iPTH were measured. Thyroid function was assessed by T3, T4 and TSH. Zinc and copper in serum were determined by flame atomic absorption spectrophotometry. Bone mineral density (BMD) measurements at lumbar and femoral regions have been done using dual x-ray absorptiometry. The dietary calcium, zinc and copper intakes were estimated by food-frequency questionnaires. RESULTS : Short stature was seen in 39.3% of our patients. Hypogonadism was seen in 22.9% of boys and 12.2% of girls. Hypoparathyroidism and primary hypothyroidism was present in 7.6% and 7.7% of the patients. About 13 % of patients had more than one endocrine complication with mean serum ferritin of 1678 +/- 955 micrograms/lit. Prevalence of lumbar osteoporosis and osteopenia were 50.7% and 39.4%. Femoral osteoporosis and osteopenia were present in 10.8% and 36.9% of the patients. Lumbar BMD abnormalities were associated with duration of chelation therapy. Low serum zinc and copper was observed in 79.6% and 68% of the study population respectively. Serum zinc showed significant association with lumbar but not femoral BMD. In 37.2% of patients serum levels of 25(OH) D below 23 nmol/l were detected. CONCLUSION : High prevalence of complications among our thalassemics signifies the importance of more detailed studies along with therapeutic interventions.

journal_name

BMC Endocr Disord

journal_title

BMC endocrine disorders

authors

Shamshirsaz AA,Bekheirnia MR,Kamgar M,Pourzahedgilani N,Bouzari N,Habibzadeh M,Hashemi R,Shamshirsaz AA,Aghakhani S,Homayoun H,Larijani B

doi

10.1186/1472-6823-3-4

keywords:

subject

Has Abstract

pub_date

2003-08-12 00:00:00

pages

issue

issn

1472-6823

pii

1472-6823-3-4

journal_volume

pub_type

杂志文章

在线工具

Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran.